OBJECTIVES: Microneedle transdermal patches are a combination of hypodermic needles and transdermal patches used to overcome the individual limitations of both injections and patches. The objective of this study was to design a minimally invasive, biodegradable polymeric recombinant human keratinocyte growth factor (rHuKGF) microneedle array and evaluate the prepared biodegradable microneedles using in vitro techniques. MATERIALS AND METHODS: Biodegradable polymeric microneedle arrays were fabricated out of poly lactic-co-glycolic acid (PLGA) using the micromolding technique under aseptic conditions, and the morphology of the microneedles was characterized using light microscopy. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was used to rule out drug-polymer interactions. Standard procedures were used to analyze the prepared microneedle arrays for in vitro drug release and to perform a microneedle insertion test. Enzyme-linked immunosorbent assay was used to quantify rHuKGF. RESULTS: The PLGA polymer was safe for use in the fabrication of rHuKGF microneedles as there was no interaction between the drug and the polymer. The fabricated rHuKGF microneedle arrays had fully formed microneedles with a height of 600 µm and a base of 300 µm. The drug from the microneedle patch was released in vitro within 30 minutes. The strength of the microneedles in the patch was good, as they were able to reach a depth of 381±3.56 µm into parafilm without any structural change or fracture. CONCLUSION: Microneedle transdermal patches were successfully prepared for rHuKGF, and their evaluation suggested excellent quality and uniformity of patch characteristics. This can have potential applications in the therapeutic arena, offering advantages in terms of reduced dosing frequency, improved patient compliance, and bioavailability.
OBJECTIVES: Microneedle transdermal patches are a combination of hypodermic needles and transdermal patches used to overcome the individual limitations of both injections and patches. The objective of this study was to design a minimally invasive, biodegradable polymeric recombinant human keratinocyte growth factor (rHuKGF) microneedle array and evaluate the prepared biodegradable microneedles using in vitro techniques. MATERIALS AND METHODS: Biodegradable polymeric microneedle arrays were fabricated out of poly lactic-co-glycolic acid (PLGA) using the micromolding technique under aseptic conditions, and the morphology of the microneedles was characterized using light microscopy. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was used to rule out drug-polymer interactions. Standard procedures were used to analyze the prepared microneedle arrays for in vitro drug release and to perform a microneedle insertion test. Enzyme-linked immunosorbent assay was used to quantify rHuKGF. RESULTS: The PLGA polymer was safe for use in the fabrication of rHuKGF microneedles as there was no interaction between the drug and the polymer. The fabricated rHuKGF microneedle arrays had fully formed microneedles with a height of 600 µm and a base of 300 µm. The drug from the microneedle patch was released in vitro within 30 minutes. The strength of the microneedles in the patch was good, as they were able to reach a depth of 381±3.56 µm into parafilm without any structural change or fracture. CONCLUSION: Microneedle transdermal patches were successfully prepared for rHuKGF, and their evaluation suggested excellent quality and uniformity of patch characteristics. This can have potential applications in the therapeutic arena, offering advantages in terms of reduced dosing frequency, improved patient compliance, and bioavailability.
Entities:
Keywords:
Transdermal drug delivery; micromoulding; microneedles; poly-lactide-co-glycolide; recombinant human keratinocyte growth factor
Authors: J S Rubin; D P Bottaro; M Chedid; T Miki; D Ron; G Cheon; W G Taylor; E Fortney; H Sakata; P W Finch Journal: Cell Biol Int Date: 1995-05 Impact factor: 3.612
Authors: Pasquale Niscola; Laura Scaramucci; Marco Giovannini; Micaela Ales; Francesco Bondanini; Luca Cupelli; Teresa Dentamaro; Michela Lamanda; Giuseppina Natale; Roberto Palumbo; Claudio Romani; Andrea Tendas; Barbara Tolu; Leano Violo; Paolo de Fabritiis Journal: Cardiovasc Hematol Agents Med Chem Date: 2009-10
Authors: Eneko Larrañeta; Jessica Moore; Eva M Vicente-Pérez; Patricia González-Vázquez; Rebecca Lutton; A David Woolfson; Ryan F Donnelly Journal: Int J Pharm Date: 2014-05-28 Impact factor: 5.875
Authors: Palanirajan V Kumar; Marwan A Abdelkarim Maki; Yeong S Wei; Lee M Tatt; Manogaran Elumalai; Shiau-Chuen Cheah; Bharathy Raghavan; Abu Bakar Bin A Majeed Journal: Curr Clin Pharmacol Date: 2019